Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
Globenewswire· 2025-12-17 13:00
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:45 p.m. PT in San Francisco. A live webcast of the presentation will be available in the investors sect ...
Rexel: Denial of rumors regarding Rexel acquisition
Globenewswire· 2025-12-17 12:58
Denial of rumors regarding Rexel acquisition In line with its communication practices, the company does not intend to comment on market rumors. Following the article published in La Lettre today, the company would nevertheless like to clarify that, as of today, it has no ongoing contacts and is not conducting any negotiations with potential buyers. The company remains focused on executing its strategy and creating value for all of its stakeholders. ABOUT REXEL GROUP Rexel, worldwide expert in the multichan ...
Stallion Uranium Announces Increase to Flow-Through Financing
Globenewswire· 2025-12-17 12:45
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce that, further to its news release dated December 12, 2025, it has increased its non-brokered private placement to gross proceeds of up to $ 6,013,250, consisting of flow-through shares of the Company to be issued as a “flow-through shar ...
Jeffs’ Brands: KeepZone AI Successfully Completes Live Pilot Demonstrating Checkpoint-Free Weapon Screening at High-Profile Event
Globenewswire· 2025-12-17 12:42
Tel Aviv, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, which recently began expanding into the global homeland security sector through advanced AI-driven solutions, today announced that its wholly owned subsidiary, KeepZone AI Inc. (“KeepZone”), has successfully completed a live operational security technology pilot of Scanary Ltd.’s (“Scanary”) next-generation conce ...
Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board
Globenewswire· 2025-12-17 12:30
DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the “Board”) has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee sinc ...
Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy
Globenewswire· 2025-12-17 12:30
Approval Triggers Milestone Payment of $7.5 Million from Sanofi; Cytokinetics Eligible to Receive Additional Milestone Payments and Royalties on Net Sales in Greater China SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that MYQORZO® (aficamten) has been approved by the China National Medical Products Administration (NMPA) for the treatment of adults with New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyo ...
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
Globenewswire· 2025-12-17 12:30
WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform designed to interpret and quantify global compound-specific, drug-regulated effects in the intact cell which is deployed for rational drug design and predictive clinical development, ...
Bombardier Announces $500 Million Debt Repayment and Confirms Deleveraging Plan on Target
Globenewswire· 2025-12-17 12:30
MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Bombardier today confirmed the company is on track to reach its previously stated net leverage ratio target of 2.0–2.5x. With the $500 million debt redemption notice announced on December 17, which is expected to close by Feb 17, 2026, the Bombardier team will have successfully reduced its long-term debt by $5.5 billion since December 2020, generating annualized interest cost savings of more than $409 million (1). This achievement reflects Bombardier’s proactive f ...
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
Globenewswire· 2025-12-17 12:30
Distribution network coverage expanded to a total of 39 countriesGARDEN CITY, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the recent signing of several key international distribution agreements for LungFit® PH, expanding its network to include Germany, Brazil, Austria, the Netherland ...
Nayax Partners with Unipaas to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms
Globenewswire· 2025-12-17 12:30
HERZLIYA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their business, today announced its strategic partnership with Unipaas, the leading embedded payments provider for SaaS platforms, to deliver a fully unified card present and online payments solution for SaaS platforms in the UK. Through this collaboration, Unipaas expands its embedded payments platform to support both digita ...